KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review

Bibliography

• Berger SL, Kouzarides T, Shiekhattar R, et al. An operational definition of epigenetics. Genes Dev 2009;23:781-3
   PubMed Web of Science ®Google Scholar
• Arrowsmith CH, Bountra C, Fish PV, et al. Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 2012;11:384-400
   PubMed Web of Science ®Google Scholar
• Allis CD, Berger SL, Cote J, et al. New nomenclature for chromatin-modifying enzymes. Cell 2007;131:633-6
   PubMed Web of Science ®Google Scholar
• Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007;129:823-37
   PubMed Web of Science ®Google Scholar
• Ohe Y, Hayashi H, Iwai K. Human spleen histone H1. Isolation and amino acid sequence of a main variant, H1b. J Biochem 1986;100:359-68
   PubMed Web of Science ®Google Scholar
• Rothbart SB, Strahl BD. Interpreting the language of histone and DNA modifications. Biochim Biophys Acta 2014;1839:627-43
   PubMed Web of Science ®Google Scholar
• Cloos PA, Christensen J, Agger K, et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 2006;442:307-11
   PubMed Web of Science ®Google Scholar
• Klose RJ, Yamane K, Bae Y, et al. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 2006;442:312-16
   PubMed Web of Science ®Google Scholar
• Whetstine JR, Nottke A, Lan F, et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006;125:467-81
   PubMed Web of Science ®Google Scholar
• Couture JF, Collazo E, Ortiz-Tello PA, et al. Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase. Nat Struct Mol Biol 2007;14:689-95
   PubMedGoogle Scholar
• Iwamori N, Zhao M, Meistrich ML, et al. The testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility. Biol Reprod 2011;84:1225-34
   PubMed Web of Science ®Google Scholar
• Trojer P, Zhang J, Yonezawa M, et al. Dynamic histone H1 isotype 4 methylation and demethylation by histone lysine methyltransferase G9a/KMT1C and the Jumonji domain-containing JMJD2/KDM4 proteins. J Biol Chem 2009;284:8395-405
   PubMed Web of Science ®Google Scholar
• Berry WL, Janknecht R. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res 2013;73:2936-42
   PubMed Web of Science ®Google Scholar
• Young LC, Hendzel MJ. The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression. Biochem Cell Biol 2013;91:369-77
   PubMed Web of Science ®Google Scholar
• Berry WL, Shin S, Lightfoot SA, et al. Oncogenic features of the JMJD2A histone demethylase in breast cancer. Int J Oncol 2012;41:1701-6
   PubMed Web of Science ®Google Scholar
• Mallette FA, Richard S. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. Cell Rep 2012;2:1233-43
   PubMed Web of Science ®Google Scholar
• Hu CE, Liu YC, Zhang HD, et al. JMJD2A predicts prognosis and regulates cell growth in human gastric cancer. Biochem Biophys Res Commun 2014;449:1-7
   PubMed Web of Science ®Google Scholar
• Ding X, Pan H, Li J, et al. Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis. Sci Signal 2013;6:ra28.1-13. S0-15
   Google Scholar
• Black JC, Manning AL, Van Rechem C, et al. KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell 2013;154:541-55
   PubMed Web of Science ®Google Scholar
• Yang ZQ, Imoto I, Fukuda Y, et al. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res 2000;60:4735-9
   PubMedGoogle Scholar
• Rui L, Emre NC, Kruhlak MJ, et al. Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell 2010;18:590-605
   PubMed Web of Science ®Google Scholar
• Hillringhaus L, Yue WW, Rose NR, et al. Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family. J Biol Chem 2011;286:41616-25
   PubMed Web of Science ®Google Scholar
• McDermott J, Jimeno A. Belinostat for the treatment of peripheral T-cell lymphomas. Drugs Today (Barc) 2014;50:337-45
   PubMedGoogle Scholar
• Labbe RM, Holowatyj A, Yang ZQ. Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential. Am J Transl Res 2013;6:1-15
   PubMed Web of Science ®Google Scholar
• Københavns Universitet. Inhibition of GASC1. WO104314; 2007
   Google Scholar
• Isis Innovation. N-Oxalylglycine, hydroxamic acid and heteroaryl derivatives as histone lysine demethylase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancer and depression. WO043866A2; 2010
   Google Scholar
• Rose NR, Ng SS, Mecinovic J, et al. Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases. J Med Chem 2008;51:7053-6
   PubMed Web of Science ®Google Scholar
• Isis Innovation. JMJD2 demethylase inhibitors. WO030108; 2011
   Google Scholar
• Sekirnik R, Rose NR, Thalhammer A, et al. Inhibition of the histone lysine demethylase JMJD2A by ejection of structural Zn(II). Chem Commun (Camb) 2009(42):6376-8
   Google Scholar
• Hamada S, Suzuki T, Mino K, et al. Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of Jumonji domain-containing protein 2 histone demethylase inhibitors. J Med Chem 2010;53:5629-38
   PubMed Web of Science ®Google Scholar
• Nagoya City University; Kansai Bunri Gakuen; Frontier Pharma Inc. Preparation of hydroxamic acid derivatives as JHDM inhibitors. JP168581; 2011
   Google Scholar
• Ueda R, Suzuki T, Mino K, et al. Identification of cell-active lysine specific demethylase 1-selective inhibitors. J Am Chem Soc 2009;131:17536-7
   PubMedGoogle Scholar
• EpiTherapeutics. Preparation of pyrido[1,2-a]indole derivatives as inhibitors of histone demethylases. WO007008; 2012
   Google Scholar
• Epitherapeutics. Inhibitors of hdme. WO2012007008; 2012
   Google Scholar
• Liang Y, Vogel JL, Arbuckle JH, et al. Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency. Sci Transl Med 2013;5:167ra5
   Google Scholar
• United States Dept. of Health and Human Services. Method of preventing or treating viral infection with compounds that inhibit JMJD2 proteins. US0123344; 2013
   Google Scholar
• The Regents of the University of Colorado. Histone demethylase inhibitors and methods for using the same. US0137720; 2013
   Google Scholar
• Luo X, Liu Y, Kubicek S, et al. A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases. J Am Chem Soc 2011;133:9451-6
   PubMed Web of Science ®Google Scholar
• Epitherapeutics. Preparation of aminomethylpyridine carboxylic acid derivatives for use as histone demethylase inhibitors. WO053491; 2014
   Google Scholar
• Rotili D, Tomassi S, Conte M, et al. Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities. J Med Chem 2014;57:42-55
   PubMed Web of Science ®Google Scholar
• Chu CH, Wang LY, Hsu KC, et al. KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor. J Med Chem 2014;57:5975-85
   PubMed Web of Science ®Google Scholar
• Heightman TD. Chemical biology of lysine demethylases. Curr Chem Genomics 2011;5:62-71
   Google Scholar
• United States Dept. of Health and Human Services. Method of preventing or treating viral infection using inhibitors of JMJD2 histone demethylases. WO012627; 2012
   Google Scholar
• Zhang QJ, Chen HZ, Wang L, et al. The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J Clin Invest 2011;121:2447-56
   PubMed Web of Science ®Google Scholar
• Rabkin SW, Klassen SS. Jumonji is a potential regulatory factor mediating nitric oxide-induced modulation of cardiac hypertrophy. J Cardiovasc Med (Hagerstown) 2009;10:206-11
   Google Scholar
• Zhao M, Liang G, Wu X, et al. Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata. Br J Dermatol 2012;166:226-73
   PubMedGoogle Scholar
• Wang KS, Liu X, Zhang Q, et al. Genome-wide association study identifies 5q21 and 9p24.1 (KDM4C) loci associated with alcohol withdrawal symptoms. J Neural Transm 2012;119:425-33
   Google Scholar
• Kantojarvi K, Onkamo P, Vanhala R, et al. Analysis of 9p24 and 11p12-13 regions in autism spectrum disorders: rs1340513 in the JMJD2C gene is associated with ASDs in Finnish sample. Psychiatr Genet 2010;20:102-8
   PubMed Web of Science ®Google Scholar
• Shi Y, Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004;119:941-53
   PubMed Web of Science ®Google Scholar
• Lohse B, Kristensen JL, Kristensen LH, et al. Inhibitors of histone demethylases. Bioorg Med Chem 2011;19:3625-36
   PubMed Web of Science ®Google Scholar
• Yu V, Fisch T, Long AM, et al. High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases. J Biomol Screen 2012;17:27-38
   Google Scholar
• Kawamura A, Tumber A, Rose NR, et al. Development of homogeneous luminescence assays for histone demethylase catalysis and binding. Anal Biochem 2010;404:86-93
   PubMed Web of Science ®Google Scholar